COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,950 Articles (22,604 medRxiv, 8,346 bioRxiv)

Most recent first Previous |  Page 279: Articles 2781-2790  | Next

Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: implications for bone health
Barclay, N. L., Catala, M., Jodicke, A. M., Prieto-Alhambra, D., Newby, D., Delmestri, A., Man, W. Y., Rosello Serrano, A., Pineda-Moncusi, M., The OPTIMA Consortium
10.1101/2023.11.09.23298305 — Posted: 2023-11-10
Post-Vaccination Syndrome: A Descriptive Analysis of Reported Symptoms and Patient Experiences After Covid-19 Immunization
Krumholz, H. M., Wu, Y., Sawano, M., Shah, R., Zhou, T., Arun, A. S., Khosla, P., Kaleem, S., Vashist, A., Bhattacharjee, B., Ding, Q., Lu, Y., Caraballo, C., Warner, F., Huang, C., Herrin, J., Putrino, D., Hertz, D., Dressen, B., Iwasaki, A.
10.1101/2023.11.09.23298266 — Posted: 2023-11-10
Emergence and spread of feline infection peritonitis due to a highly pathogenic canine/feline recombinant coronavirus
Atippa, C., Warr, A. S., Epaminondas, D., O'Shea, M., Fletcher, S. L., Malbon, A., Lyraki, M., Hammond, R., Hardas, A., Zanti, A., Loukaidou, S., Gentil, M., Gunn-Moore, D., Mazeri, S., Tait-Burkard, C.
10.1101/2023.11.08.566182 — Posted: 2023-11-09
Robust detection of SARS-CoV-2 exposure in population using T-cell repertoire profiling
Vlasova, E. K., Nekrasova, A. I., Komkov, A. Y., Izraelson, M., Snigir, E. A., Mitrofanov, S. I., Yudin, V. S., Makarov, V. V., Kesnikov, A. A., Kirienko, D., Pivnyuk, A., Shelyakin, P. V., Mamedov, I. Z., Rebrikov, D. V., Chudakov, D. M., Yudin, S. M., Skvortsova, V. I., Britanova, O., Shugay, M. A.
10.1101/2023.11.08.566227 — Posted: 2023-11-09
Attila and Aetius on the roof: The succession phenomenon in the roof greening area of a primary school in Beijing during the lockdown period of the COVID-19
Wu, R., Guan, J., Xia, Z., Zhang, T., Jiang, Y., Wang, Z.
10.1101/2023.11.07.565953 — Posted: 2023-11-09
East-West mortality disparities during the COVID-19 pandemic widen the historical longevity divide in Europe.
Shkolnikov, V. M., Timonin, S., Jdanov, D., Islam, N., Leon, D. A.
10.1101/2023.11.08.23298275 — Posted: 2023-11-09
A Systematic Review of the Attitude, Beliefs, and Acceptance of COVID-19 Vaccine in the Western and Eastern Hemisphere.
Chander, S., Kumari, R., Luhana, S.
10.1101/2023.11.08.23298274 — Posted: 2023-11-09
Real-world effectiveness of non-pharmaceutical interventions in containing COVID-19 pandemic after the roll-out of coronavirus vaccines: A systematic review
Xiaona, H., Chen, H., Zhu, X., Gao, W.
10.1101/2023.11.07.23297704 — Posted: 2023-11-08
Combining genomic data and infection estimates to characterize the complex dynamics of SARS-CoV-2 Omicron variants in the United States
Lopes, R., Pham, K., Klaassen, F., Chitwood, M. H., Hahn, A., Redmond, S., Swartwood, N. A., Salomon, J. A., Menzies, N. A., Cohen, T., Grubaugh, N. D.
10.1101/2023.11.07.23298178 — Posted: 2023-11-08
Small Fiber Neuropathy after COVID-19: A Key to Long COVID
McAlpine, L., Zubair, A., Joseph, P., Spudich, S.
10.1101/2023.11.07.23297764 — Posted: 2023-11-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).